Coherus BioSciences, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Coherus BioSciences, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2014 to Q2 2024.
  • Coherus BioSciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $7.23M, a 28.2% decline year-over-year.
  • Coherus BioSciences, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $43.1M, a 15% decline from 2022.
  • Coherus BioSciences, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $50.7M, a 1.22% decline from 2021.
  • Coherus BioSciences, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $51.4M, a 34.6% increase from 2020.
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $7.23M -$2.85M -28.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $7.32M -$4.96M -40.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q2 2023 $10.1M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $12.3M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2021 $800K Feb 1, 2021 Feb 28, 2021 10-K 2024-03-15
Q2 2015 $4.62M +$3.54M +329% Apr 1, 2015 Jun 30, 2015 10-Q 2015-08-10
Q1 2015 $2.18M +$1.69M +343% Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-11
Q2 2014 $1.08M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 $491K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.